Abstract
Introduction
Gestational diabetes mellitus is de ned as "any degree of glucose intolerance with onset or rst recognition during pregnancy" 1,2. is condition includes women whose glucose tolerance will return to normal after pregnancy and those who will persist with glucose intolerance and type 2 Diabetes Mellitus. 3 It is the most common medical problem and metabolic complication in pregnancy and 3% to 25% of total pregnancies may be a ected by GDM. 3 e incidence of GDM in primi-gravida of Bangladesh is 13.7% and out of this 12.5% found in rst trimester, 31.2% is in second trimester and 56.3% in third trimester. 4 GDM is associated with adverse pregnancy outcomes and the subsequent development of diabetes in mothers. 5, 6, 7 Pregnancy is a complex metabolic endocrine process. Insulin resistance usually begins in the second trimester of pregnancy and progress throughout the pregnancy. On the basis of this, screening is done on 24th to the 28th weeks of gestation. 8 Normal glucose tolerance in early pregnancy does not exclude the risk of development of GDM later.Oxidative stress plays an important role in the pathphysiology of GDM. 9 Serum gamma glutamyl transferase plays an important role in oxidative stress and recently it has been recognized as a marker of oxidative stress. 10 Gamma-glutamyl transferase (GGT) is an ectoplasmic enzyme responsible for the extracellular catabolism of glutathione (GSH). e enzyme is produced in many tissues, but mainly derived from liver. 11 ere is a link between pre-gravid liver enzyme level and risk of gestational diabetes during a subsequent pregnancy and highest quartile of GGT level was associated with a twofold increased risk of subsequent GDM. 12 Oxidative stress is the condition of increased free radical activity and high lipid oxidation. It plays a role in etiology of type 2 diabetes by inducing insulin resistance in the peripheral tissue and impairing insulin secretion from pancreatic β-cell. 13, 14 Elevated GGT is strongly associated with obesity and excess deposition of fat in the liver, termed as non-alcoholic fatty liver disease. It is thought to caused by hepatic insulin resistance and contribute to the development of systemic insulin resistance which is *Unpaired"t" Test was done to measured the level of signi cance; S=Signi cant, NS=Not signi cant, Group-I = GDM, Group -II= Normal pregnancy Signi cant positive correlation between GGT and fasting blood glucose level in GDM group was found. Pearson correlation value was 0.35(p< 0.05), that means there is 35% possibility that FBS increases when GGT is increased. (Figure-1) implicated in the pathogenesis of type 2 DM. 15 ere are some hematological and biochemical predictor for GDM i.e. GGT, ALT, PCT (plateletcrit), PDW (platelet distribution width) adioponectin, follistatin like-3, sex hormone binding globulin. 16, 17 ALT is a marker for liver fat accumulation and is more speci c for liver pathology. 12 Other than liver, GGT is also found in other tissues and is less speci c for liver pathology. 18 PCT, PDW is measured by modern hematological auto analyzer which is not available in all the areas of our country. Adioponectin, Follistatin like-3, sex hormone binding globulin is very expensive test and not available in rural areas or all the centers of our country.
Gamma-glutamyl transferase is an indicator of gestational diabetes mellitus
On the other hand, measurement of GGT is simple, automated, cheap and easy to carry out. So, for the assessment of risk of gestational diabetes mellitus, this test may be used as an alternative screening method for GDM that does not require glucose ingestion and waiting for a blood sample that is more hazardous for the patient. It can be used for predicting the possibility of type 2 DM. GGT may help to identify risk group women who would bene t from interventions during the early pregnancy period.
Methods
is cross sectional study was conducted in the Department of Clinical pathology , in collaboration with the Department of Obstetrics and Gynecology, Bangabandhu Sheikh Mujib Medical University (BSMMU), Shahbag, Dhaka from March 2014 to February 2015. Total 66 pregnant women were enrolled in this study. Among them, 33 pregnant women with GDM were considered as Group I and 33 normal pregnant women with out GDM were were Group II and considered as controls.
Previous diagnosis of DM, pre-eclampsia, pregnant women with systemic disease (HTN, onnective tissue disease, heart disease, renal disease, chronic liver disease), history of taking alcohol and some drugs that a ects GGT (Phenytoin, phenobarbital, acetaminophen) were excluded from the study. In this study patients' gamma glutamyl transferase were measured by biochemistry auto analyzer (Simens Dimension Max) in the Department of Clinical Pathology, BSMMU.
After selection, all the patients were thoroughly informed about the aims, objectives and procedure of the study. An informed written consent was taken from each subject. Detailed personal, medical and educational history, gestational weeks, family history of DM, previous history of GDM, para and gravida were recorded. orough physical examinations were done and documented. Gamma glutamyl transferase was measured by biochemistry auto analyzer. Fasting plasma glucose, plasma glucose 2 hours after 75 g glucose were also done.
Figure-2 : Correlation between GGT and FBS in normal pregnancy group (n=33)
Signi cant positive correlation between GGT and fasting blood glucose level in normal pregnancy group was found. Pearson Correlation value was 0.07(p> 0.05), that means there is 7% possibility that FBS increases when GGT is increased; but it was statistically not signi cant (p 0.05). (Figure- e FBS, 2h after 75g glucose and GGT of GDM group were signi cantly higher than normal group when compared by unpaired "t" test (p <0.05). (Table-II Chi-Square Test
Discussion
e high prevalence of GDM is increasing globally and 3% to 25% of total pregnancy may be a ected by GDM. 3 It is the most common metabolic complication in pregnancy. Serum GGT remains normal during pregnancy. 19 In our study gestational age of GDM (Group I) was 30-39 weeks and in normal pregnancy (Group II) it was 30-38 weeks. is di erence was statistically not signi cant (p<0.05). GDM and type 2 diabetes mellitus share several risk factors and the incidence of GDM re ects the prevalence of type 2 diabetes mellitus.
Age (>25 years) is a risk factor in case of GDM. 4 In our study the mean age of the patients with GDM (Group I) was 26.69± 4.60 years and range were 20-36 years. e mean age of the normal healthy pregnant women (Group II) was 26.87±6.57 years and range was 17-40 years. e di erence of mean age was not statistically signi cant among two groups (p>0.05). is ndings are consistent with the ndings of other studies. 12, 20 Sridhar SB and co-investigators showed that the mean age of GDM was 28.26±5.5 years and the mean age of control was 28.46±5.2. ese ndings were similar to our study.
In our study, mean FBG were 5.10 (±1.26) mmol\L and 4.53(±0.65)mmol\L in GDM group & normal pregnancy group respectively. Mean value of blood glucose 2hr after 75g glucose were 9.75(±1.52) mmol\L in GDM group and 6.27(±0.85)mmol\L in normal pregnancy Group (p<0.05). e FBG, 2h after 75g glucose and GGT of GDM group were signi cantly higher than normal pregnancy group when compared by unpaired "t" test (p<0.05).
Our study showed signi cant positive correlation between GGT with fasting blood glucose level in GDM group. Pearson correlation value was 0.35 (p <0.05) that means there is 35% possibility that FBS increases when GGT is increased. In normal pregnancy group, there was also positive correlation between GGT & FBG and pearson correlation value was 0.07. But it was statistically not signi cant (p >0.05).
Receiver operator characteristic curve analysis shows that, cuto value of GGT was set at 19.50, sensitivity was calculated 98% and speci city was 50%. is result is similar to other studies. 12, 16, 21, 22 Another study showed that GGT in the GDM group were higher than normal control & that was statistically signi cant (p <0.05). 16 Other study showed that cut o value of GGT was 16 IU/L, the sensitivity was 86%, and speci city was 37%. 22 is is approximately similar to our study.
In our study the mean GGT values were higher in the GDM group than normal control. A study showed that cut o value of GGT was 24IU/L. 21 In this study, raised GGT had a sensitivity of 23.2% and speci city of 86.1%. is sensitivity and speci city is not similar with our study.
e probable reason was that, they also used GGT as a diagnostic marker. Sridhar SB et al showed that the mean GGT were 28±21.7 U/L & 22±16.6 U/L in GDM group and in normal control group respectively; it was statistically highly signi cant (p <0.05).
Our study showed that GGT was higher in GDM group than normal control. Signi cant positive correlation was found between GGT with FPG and 2hr after 75g glucose. GGT can be used as a simple and cost e ective indicator for identi cation of risk group women for GDM and earlier prevention of the GDM in pregnant women.
is study was done in a limited span of time. e main limitation of our study was the small sample size and this was a non-randomized single center study. All the confounding variables in uencing GGT were not investigated extensively.
